Clinical trial
Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic…
NCT00409461 · AZ-VUB, Other · Terminated
Key facts
| NCT number | NCT00409461 |
|---|---|
| Title | Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts |
| Official title | Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts |
| Lead sponsor | AZ-VUB, Other |
| Collaborators | Fund for Scientific Research, Flanders, Belgium Belgian Government |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Islet Transplantation, Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | ATG-Sirolimus-Tacrolimus |
| First posted | Dec 11, 2006 |
| Last update posted | Dec 11, 2006 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: